Ontology highlight
ABSTRACT: Background
Neuromuscular blocking agents may improve outcomes in specific conditions, including the early phase of acute respiratory distress syndrome. However, neuromuscular blocking agents are associated with side effects and uncertainty persists regarding their optimal dosing and efficacy. Our objective was to describe the use of neuromuscular blocking agents in a real-world setting.Methods
We conducted a multicenter, prospective observational study, including adult patients who underwent invasive mechanical ventilation and received a continuous infusion of neuromuscular blocking agents. Patients were recruited across 19 intensive care units in France and Belgium.Results
From November 16, 2019, to February 19, 2020, a total of 2248 patients were hospitalized and
SUBMITTER: Hermann B
PROVIDER: S-EPMC12546236 | biostudies-literature | 2025 Oct
REPOSITORIES: biostudies-literature